Anna Vorobyeva, Ph.D. Email & Phone Number

Boulder, Co, Us

New York, New York, Us

Equity research associate on SMID Biopharma team. Team covers 15 EU and 26 US companies (Mcap range $200mn-$28bn) of which majority efforts were devoted to IPO and FO transactions.

Newport Beach, Ca, Us

• Work jointly with a top-tier Wall Street Equity Research Senior Analyst in covering approximately 20 SMid-cap biotech companies and monitor a number of other public and private companies within related competitive landscape.• Conduct extensive in-depth qualitative & quantitative due diligence to draft initiations, industry, earnings, and company notes.• Draft and maintain company financials and market valuation models. Follow FDA guidance updates for clinical trial design.• Actively participate in company calls, 1x1 meetings, analyst and investor conferences as well as academic global conferences to enhance subject matter expertise and build additional relationships with biotech companies and Key Opinion Leaders.• Provide daily fundamental support to the Senior Analyst by consistently communicating with Key Opinion Leaders, company executive management, sales force, and investors.

New York, Ny, Us

• Characterized novel risk autism-associated single nucleotide variations in genes encoding protein synthesis regulatory protein kinases and how they contribute to autism spectrum disorders and associated comorbidities using cells and animal models.• Carried out hypothesis-driven and detail-oriented research & analysis of each gene and risk SNV.• Trained and managed students to efficiently execute proposed project goals.• Established core research facility and negotiated contracts with vendors resulting in: cutting laboratory costs, and rapid launch of new research thus reducing time to milestones and anticipated deliverables.• Researched, analyzed, synthesized and communicated research conclusions and recommendations for future research based on forecast pharmacoeconomic trends to both technical and nontechnical audience at large global conferences.• Advised and consulted senior leaders on critical decision-making for current laboratory tangible and intangible asset investments to impact future laboratory talent and expertise.• Served as a crucial interface contact with key members of regulatory advisory board for conducting research.• Established collaborations with academic institutions, research centers, and nonprofits.• Provided fundamental written grantsmanship support.Technical

Philadelphia, Pennsylvania, Us

• Characterized novel risk genes and how they contribute Alzheimer's disease neuropathology in the context of the underlying molecular mechanism of Amyloid Precursor Protein biology and Amyloid-Beta production. • Characterized a naturally occurring plant phytosterol compound for Alzheimer's disease treatment.• Discovered and analyzed Shh in the construct of APP biology and a putative role of Amyloid-beta fragment in damaging neuronal primary cilia and disrupting pro-survival Shh signaling crosstalk.• Established working model, executed hypothesis-driven research, developed and trained students to rapidly execute project goals with exceptional accuracy & precision.• Composed grant proposals, maintained close collaborations and disseminated technical results to lay and expert audiences.Technical: Data collection & data analysis, genetics, DNA engineering, surgical techniques, in vivo models, in vitro cell-based and ex vivo -based disease models, biochemistry, microscopy, pharmacological assays, primary neuronal cell culture.Public talk example: https://youtu.be/IqOFej-bdhAPub: Vorobyeva AG, Lee R, Miller S, Longen C, Sharoni M, Khandelwal PJ, Kim FJ, Marenda DR, Saunders AJ. Cyclopamine Modulates Gamma-Secretase Mediated Cleavage of Amyloid Precursor Protein by Altering its Subcellular Trafficking and Lysosomal Degradation. J Biol Chem. 2014 Oct 3; PubMed.

Philadelphia, Pennsylvania, Us

• Developed teaching material and evaluated student performance & progress (student body size ranged from 10-150 students). • Courses: Essential Biology for non-majors, Microbiology, Advanced Cell Biology, Cells & Genetics, Cell Molecular & Developmental Biology.

• Performed data analysis and examined patentability and commercialization potential of innovation/discovery.• Drafted documents for patent applications and novel technology licensing.

New Brunswick, Nj, Us

Overview: Performed key operations for Johnson & Johnson Skin Pharmacology R&D platform. • Research projects: Aveeno, Neurtogena Suncare, RoC Skincare Anti-Aging. • Tested various in vitro and ex vivo working models to execute proof-of-principle/concept (PoP/PoC) studies of biomolecules & systematically identified appropriate delivery system and efficacy levels against skin inflammation • Presented key findings to Johnson & Johnson managers, supervisors, and VP of R&D. Technical: Data collection, data analysis, skin biology, skin inflammation, immunology, biochemistry, in vitro & ex-vivo cell-based models, high throughput platforms, bioanalyzers, skin graft models, PoP/PoC studies, microscopy.

Glenside, Pa, Us

Glenside, Pa, Us

Forensic Science Elective

Philadelphia, Pa, Us

• Analyzed cellular immune response to viral challenge. • Played an integral role in a research team with a common goal to study measles and poliovirus resulting in 1 publication in an international peer-reviewed immunology journal.Technical

Translated school documents & parent-teacher conferences.

Ph.D., Cellular And Molecular Biology

Value Investing

Certificate, Business Of Science

Bs, Biology